Journal profile · Medicine-General Medicine
European Journal of Clinical and Experimental Medicine
ISSN 2544-2406 · eISSN 2544-1361 · Publishing Office of the University of Rzeszów · Poland
European Journal of Clinical and Experimental Medicine: diamond open access (no APC); no APC; review about 50 days (submission to final decision, publisher); 132 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
European Journal of Clinical and Experimental Medicine is published by Publishing Office of the University of Rzeszów. By OpenAlex counts of its recent articles, its largest topics are Medical Practices and Rehabilitation, Stroke Rehabilitation and Recovery and Musculoskeletal pain and rehabilitation, together about 27.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
GENERAL INFORMATION The European Journal of Clinical and Experimental Medicine (Eur J Clin Exp Med) is an internationally recognized, peer-reviewed, open-access journal published by the Rzeszów University Press. The journal is issued quarterly in an online format and publishes exclusively in English. Submissions are accepted in English only, ensuring accessibility to a global audience. Eur J Clin Exp Med is committed to promoting the dissemination of high-quality research that advances knowledge in clinical and experimental medicine. With its open-access model introduced in 2020, the journal ensures that all published articles are freely available for access, download, and sharing without any subscription barriers. THE THEMATIC SCOPE The European Journal of Clinical and Experimental Medicine publishes original research, reviews, and case studies that contribute to advancements in medical science and practice. The journal covers a broad range of topics within life and health sciences, clinical medicine, experimental medicine, and interdisciplinary research. Eur J Clin Exp Med welcomes submissions that address current challenges and emerging trends in medicine, fostering collaboration and the exchange of knowledge across related disciplines. All published articles are freely accessible, promoting the unrestricted use and application of scientific discoveries worldwide. JOURNAL METRICS (2025) Rejection rate 68% The average time for initial technical and formal verification of the manuscript by the editor 2 days The average time from submission to the first decision 30 days The average time from submission to the final decision 50 days The average time in which the article is published in the online first version 80 days The average time in which the article is published in the final version (from submission to publication) 250 days JOURNAL TITLE HISTORY European Journal of Clinical and Experimental Medicine2017 – current, e-ISSN: 2544-1361, p-ISSN: 2544-2406, DOI: 10.15584/ejcem. Medical Review2015-2016, ISSN: 2450-6761, DOI: 10.15584/medrev. Przegląd Medyczny Uniwersytetu Rzeszowskiego i Narodowego Instytutu Leków w Warszawie2011-2015, ISSN: 2082-369X, DOI: doi: 10.15584/przmed. Przegląd Medyczny Uniwersytetu Rzeszowskiego2003-2010, ISSN: 1730-3524 Przegląd Naukowy Instytutu Wychowania Fizycznego i Zdrowotnego Uniwersytetu Rzeszowskiego2001-2003, ISSN: 1642-5936 Przegląd Naukowy Instytutu Wychowania Fizycznego i Zdrowotnego WSP w Rzeszowie1997-2001, ISSN: 14
From the journal's Aims & Scope
Research area (LetPub): Medicine-General Medicine
Editorial board by country: 1 in mainland China (about 1%); most named Poland 27, Ukraine 8, United States 6, Slovakia 4, Germany 3 (69 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Practices and RehabilitationHealth Professions10.4%
- Stroke Rehabilitation and RecoveryMedicine9.2%
- Musculoskeletal pain and rehabilitationMedicine8%
- Balance, Gait, and Falls PreventionHealth Professions4.8%
- COVID-19 Clinical Research StudiesMedicine4.2%
- Acute Ischemic Stroke ManagementMedicine4.2%
- Physical Activity and HealthMedicine4.2%
- Human Health and DiseaseMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| General Medicine | Q3 | 480/669 | — |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.16LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 18OpenAlex ·
- 2-year mean citedness
- 0.69OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,360 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 69 | 69 | 250 |
| 2025 | 132 | 132 | 241 |
| 2024 | 128 | 128 | 158 |
| 2023 | 117 | 117 | 148 |
| 2022 | 68 | 68 | 101 |
| 2021 | 78 | 78 | 82 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
50 dayssubmission to final decision · community reports about 21 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 21 weeksLetPub ·
- Submission to first decision
- 30 daysPublisher website ·
- Submission to final decision
- 50 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 200 words
- Keywords
- 3–6
- Manuscript length
- ≤ 4,500 words
- Reference style
- AMA
- Templates
- Word
- Suggested reviewers
- Optional
- Cover letter
- Required
Article types accepted2
- editorialWhen you submit a manuscript to the Eur J Clin Exp Med, we will take it to imply that the manuscript has not already been published or submitted elsewhere. If s…Length not stated
- reviewsThese provide concise and precise updates on the latest progress made in a given area of research. Systematic reviews should follow the PRISMA guidelines.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Declaration of use of AI and AI-assisted technologies in the writing process
Authors are required to disclose the use of generative AI in the writing of scientific papers upon submission. This guidance applies solely to the writing process and does not pertain to the use of AI tools for data analysis or drawing insights as part of the research process. Generative AI and AI-assisted technologies should be used in the writing process solely to enhance the readability and lan…
Source ↗Publisher website ·- Authorship Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before a final acceptance decision, and only if approved by the journal Editor. To request such a change, the …
Source ↗Publisher website ·- Conflicts of interest Competing interests policy
In the interests of transparency and to help readers form their own judgments of potential bias, authors must declare any competing financial and/or non-financial interests related to the work described. Competing interests are defined as financial or non-financial relationships or circumstances that could directly influence, or be perceived to influence, the objectivity, integrity, or interpretat…
Source ↗Publisher website ·- Data availability Data availability statement format guidelines
The statement should be provided as a separate section (titled 'Data Availability') at the end of the main text, before the 'References' section. Data availability statements should include, where applicable, accession codes, other unique identifiers and associated web links for publicly available datasets, and any conditions for access of non-publicly available datasets. Where figure source data …
Source ↗Publisher website ·- Publication ethics Handling complaints and allegations of misconduct
COPE member Model summary
The journal follows COPE guidance for handling allegations of misconduct (e.g., plagiarism, data fabrication/falsification, unethical research, authorship manipulation, peer-review manipulation). Allegations may be reported to the Editorial Office. The Editor-in-Chief (or a delegated editor without conflicts of interest) will conduct an initial assessment and, when appropriate, request explanation…
Source ↗Publisher website ·- License & copyright Open access and creative commons
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without fina…
Source ↗Publisher website ·- Open access Open access and creative commons
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without fina…
Source ↗Publisher website ·- Peer review Peer-review process
Initial checks Once submitted, your manuscript will be assigned to a member of our Editorial Board, who will read the paper and decide whether it is appropriate for the journal. Manuscripts that are within scope and seem, on initial assessment, to be technically sound and scientifically valid, will be sent to external reviewers. Copies of any papers containing similar or related work under conside…
Source ↗Publisher website ·- Preprints Preprint policy
Preprint policy Model summary
The Eur J Clin Exp Med permits the posting of manuscripts on recognized preprint servers prior to submission or during the peer review process. Authors must disclose the existence of any preprint version at the time of submission and provide the preprint DOI or URL. Preprints are not considered peer-reviewed publications and must not be cited as references in manuscripts submitted to the Eur J Cli…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
Clinical trials must comply with all policies related to research involving human subjects. Additionally, the Eur J Clin Exp Med adheres to the guidelines set by the International Committee of Medical Journal Editors (ICMJE), which mandate the registration of clinical trials in a public trials registry prior to or at the time of the first patient enrollment as a prerequisite for publication consid…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Publishing Office of the University of Rzeszów
- Country or region
- Poland
- Language
- English
- ISSN
- 2544-2406
- Electronic ISSN
- 2544-1361
- Latest issue on the website
- Volume 24, Issue 2 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about European Journal of Clinical and Experimental Medicine
How long does peer review take at European Journal of Clinical and Experimental Medicine?
The publisher reports about 50 days (submission to final decision); authors report an average review time of about 21 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of European Journal of Clinical and Experimental Medicine?
According to the journal's author guidelines: Abstract: ≤ 200 words; Keywords: 3–6; Manuscript length: ≤ 4,500 words; Reference style: AMA; Templates: Word; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of European Journal of Clinical and Experimental Medicine based?
Of the 69 board members whose country the journal's board page names, 1 (about 1%) are in mainland China; the countries named most often are Poland (27), Ukraine (8) and United States (6). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Clinical and Experimental Medicine?
According to LetPub and DOAJ records, European Journal of Clinical and Experimental Medicine is indexed in Scopus and DOAJ.
Is European Journal of Clinical and Experimental Medicine open access, and what is the APC?
European Journal of Clinical and Experimental Medicine is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .